Ankylosing spondylitis
We specifically reduce inflammatory activity in the spine, preventing stiffness and ossification of the joints.
About the disease
Ankylosing spondylitis (Bechterew's disease) is a chronic inflammation of the spinal joints.
The modified T-cell vaccination technology is applied to control inflammatory activity.
Inflammation control
Reduction of process activity in the spine.
Mobility
Preserving flexibility and preventing fusions.
Selectivity
Impact on pathogenic cells.
T-cell vaccination
The method aims to stimulate immune reactions selectively directed at inactivating pathogenic autoimmune T-lymphocytes.
Collection and isolation
Autoaggressive T-lymphocytes — cells attacking the body's own tissues — are isolated from your blood.
Vaccine preparation
The isolated cells are processed and used to create a personalized T-cell vaccine.
Vaccination
Administering the vaccine triggers a regulatory immune response that selectively suppresses only the pathogenic cell clones.
Monitoring and support
Inflammatory activity decreases without suppressing general immunity; the course is adjusted based on dynamics.
Other directions
Multiple sclerosis
Selective inactivation of aggressive lymphocytes to protect the myelin sheath of nerve fibers.
Rheumatoid arthritis
Relief of joint inflammation and restoration of mobility without suppressing general immunity.
Autoimmune vasculitis
Relieving inflammation of the vascular wall to restore normal blood circulation.
Discuss your situation
Leave your contact details. Our medical coordinator will contact you shortly to answer any questions.